News Search

Category: School of Medicine

Philly Nonprofit Awarded $48 Million to Apply AI in Search for New Uses for Approved Drugs  

AI based on specific algorithms will scan tens of thousands of approved medications and rare diseases to find potential matches.

Penn Leaders Featured in the Philadelphia Business Journal’s Power 100 List 

PCI congratulates these Penn leaders for their inclusion in the Philadelphia Business Journal's list of "100 business leaders set to shape Philadelphia in 2024."  

Featured Technology: Penn Medicine AInSights Technology 

Penn Medicine's AInSights is a cloud-based machine learning platform accessible by clinicians for real-time image analysis supporting multiple machine learning algorithms.

The Future Applications of Penn Medicine’s mRNA Technology 

Weissman has partnered in building 18 mRNA-capable Good Manufacturing Practice (GMP) sites to date across the world.

Penn health system profits support medical research and teaching over past decade 

Penn was highlighted in the Philadelphia Inquirer for investing $2 billion in profits from its health system into medical research and physician support over the past decade.

PCI Showcases Penn’s Neuroscience Innovation at JP Morgan Healthcare Conference

The program was well attended by professionals from across the globe in pharma, medtech and biotech industries and offered an incredible opportunity for networking and connection.

Penn Nobel-Prize Winners Receive Warm Welcome in Sweden

Karikó and Weissman were celebrated at several days of ceremonies and festivities in Sweden, two months after first learning the news.

More than 260,000 Penn Medicine patients have agreed to share their DNA for research via Penn Medicine BioBank

By obtaining samples from a wide-cross section of humanity, researchers are able to cross-reference participants’ DNA with their health records and identify genetic variants for a range of diseases. 

Long-term Penn Research Across Disciplines Leads to the Development of a New ‘Patch’ that Uses Natural Body Motion to Fix Disc Herniation

A new biologic “patch” that is activated by a person’s natural motion has the potential to fix herniated discs in people’s backs, according to researchers at Penn Medicine and the CMC VA Medical Cente

Carisma Therapeutics Receives FDA Clearance of  Investigational New Drug Application for CT-0525, a Novel CAR-M Cell Therapy 

Having received a Study May Proceed notification from the FDA, Carisma plans to initiate a Phase 1 study in the months to come and to treat the first patient in the first half of 2024.


Skip to content